Mostrar el registro sencillo del ítem
Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy
dc.contributor.author | Jaikuna, T. | * |
dc.contributor.author | Osorio, E.V. | * |
dc.contributor.author | Azria, D. | * |
dc.contributor.author | Chang-Claude, J. | * |
dc.contributor.author | De Santis, M.C. | * |
dc.contributor.author | Gutiérrez-Enríquez, S. | * |
dc.contributor.author | van Herk, M. | * |
dc.contributor.author | Hoskin, P. | * |
dc.contributor.author | Lambrecht, M. | * |
dc.contributor.author | Lingard, Z. | * |
dc.contributor.author | Seibold, P. | * |
dc.contributor.author | Seoane, A. | * |
dc.contributor.author | Sperk, E. | * |
dc.contributor.author | Symonds, R.P. | * |
dc.contributor.author | Talbot, C.J. | * |
dc.contributor.author | Rancati, T. | * |
dc.contributor.author | Rattay, T. | * |
dc.contributor.author | Reyes, V. | * |
dc.contributor.author | Rosenstein, B.S. | * |
dc.contributor.author | de Ruysscher, D. | * |
dc.contributor.author | Vega Gliemmo, Ana | * |
dc.contributor.author | Veldeman, L. | * |
dc.contributor.author | Webb, A. | * |
dc.contributor.author | West, C.M.L. | * |
dc.contributor.author | Aznar, M.C. | * |
dc.date.accessioned | 2025-09-08T12:21:25Z | |
dc.date.available | 2025-09-08T12:21:25Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Jaikuna T, Osorio EV, Azria D, Chang-Claude J, De Santis MC, Gutiérrez-Enríquez S, et al. Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy. Breast. 2023;72. | |
dc.identifier.issn | 1532-3080 | |
dc.identifier.other | https://portalcientifico.sergas.gal//documentos/6522c808ec1a10197ffd9801 | |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/21270 | |
dc.description.abstract | Background: Normal tissue complication probability (NTCP) models can be useful to estimate the risk of fibrosis after breast-conserving surgery (BCS) and radiotherapy (RT) to the breast. However, they are subject to uncertainties. We present the impact of contouring variation on the prediction of fibrosis. Materials and methods: 280 breast cancer patients treated BCS-RT were included. Nine Clinical Target Volume (CTV) contours were created for each patient: i) CTV_crop (reference), cropped 5 mm from the skin and ii) CTV_skin, uncropped and including the skin, iii) segmenting the 95% isodose (Iso95%) and iv) 3 different auto-contouring atlases generating uncropped and cropped contours (Atlas_skin/Atlas_crop). To illustrate the impact of contour variation on NTCP estimates, we applied two equations predicting fibrosis grade ? 2 at 5 years, based on Lyman-Kutcher-Burman (LKB) and Relative Seriality (RS) models, respectively, to each contour. Differences were evaluated using repeated-measures ANOVA. For completeness, the association between observed fibrosis events and NTCP estimates was also evaluated using logistic regression. Results: There were minimal differences between contours when the same contouring approach was followed (cropped and uncropped). CTV_skin and Atlas_skin contours had lower NTCP estimates (?3.92%, IQR 4.00, p < 0.05) compared to CTV_crop. No significant difference was observed for Atlas_crop and Iso95% contours compared to CTV_crop. For the whole cohort, NTCP estimates varied between 5.3% and 49.5% (LKB) or 2.2% and 49.6% (RS) depending on the choice of contours. NTCP estimates for individual patients varied by up to a factor of 4. Estimates from "skin" contours showed higher agreement with observed events. Conclusion: Contour variations can lead to significantly different NTCP estimates for breast fibrosis, highlighting the importance of standardising breast contours before developing and/or applying NTCP models. | |
dc.description.sponsorship | REQUITE received funding from the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 601826. We thank all patients who participated in the REQUITE study and all study personnel involved in the REQUITE project. Marianne Aznar acknowledges the support of the Engineering and Physical Sciences Research Council (Grant number EP/T028017/1) This work was supported by Cancer Research UK RadNet Manchester [C1994/A28701] and the NIHR Manchester Biomedical Research Centre (NIHR203308) . The researchers at DKFZ also thank Anusha Mueller, Irmgard Helmbold, Thomas Heger, Sabine Behrens, Juan Camilo Rosas. Petra Seibold was supported by ERA PerMed 2018 funding (BMBF #01KU1912) and BfS funding (#3619S42261) . S. Gutierrez-Enriquez is supported by the Government of Catalonia 2021SGR01112. | |
dc.language | eng | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject.mesh | Female | * |
dc.subject.mesh | Humans | * |
dc.subject.mesh | Radiotherapy Dosage | * |
dc.subject.mesh | Breast Neoplasms | * |
dc.subject.mesh | Breast | * |
dc.subject.mesh | Radiotherapy Planning, Computer-Assisted | * |
dc.subject.mesh | Probability | * |
dc.subject.mesh | Fibrocystic Breast Disease | * |
dc.subject.mesh | Fibrosis | * |
dc.title | Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy | |
dc.type | Artigo | |
dc.authorsophos | Jaikuna, T.; Osorio, E.V.; Azria, D.; Chang-Claude, J.; De Santis, M.C.; Gutiérrez-Enríquez, S.; van Herk, M.; Hoskin, P.; Lambrecht, M.; Lingard, Z.; Seibold, P.; Seoane, A.; Sperk, E.; Symonds, R.P.; Talbot, C.J.; Rancati, T.; Rattay, T.; Reyes, V.; Rosenstein, B.S.; de Ruysscher, D.; Vega, A.; Veldeman, L.; Webb, A.; West, C.M.L.; Aznar, M.C. | |
dc.identifier.doi | 10.1016/j.breast.2023.103578 | |
dc.identifier.sophos | 6522c808ec1a10197ffd9801 | |
dc.journal.title | Breast | * |
dc.organization | Fundación Pública Galega de Medicina Xenómica | |
dc.relation.projectID | European Union's Seventh Framework Programme for research, technological development, and demonstration [601826] | |
dc.relation.projectID | Engineering and Physical Sciences Research Council [601826] | |
dc.relation.projectID | European Union [EP/T028017/1] | |
dc.relation.projectID | European Union | |
dc.relation.projectID | Cancer Research UK RadNet Manchester | |
dc.relation.projectID | Engineering and Physical Sciences Research Council [EP/T028017/1] | |
dc.relation.projectID | Engineering and Physical Sciences Research Council | |
dc.relation.projectID | NIHR Manchester Biomedical Research Centre | |
dc.relation.projectID | NIHR Manchester Biomedical Research Centre [C1994/A28701] | |
dc.relation.projectID | NIHR Manchester Biomedical Research Centre | |
dc.relation.projectID | ERA PerMed 2018 funding (BMBF) | |
dc.relation.projectID | ERA PerMed [C1994/A28701] | |
dc.relation.projectID | ERA PerMed | |
dc.relation.projectID | BfS funding | |
dc.relation.projectID | BfS [NIHR203308] | |
dc.relation.projectID | BfS | |
dc.relation.projectID | Government of Catalonia | |
dc.relation.projectID | Government of Catalonia | |
dc.relation.projectID | Government of Catalonia | |
dc.relation.projectID | Cellex Foundation | |
dc.relation.projectID | Cellex Foundation | |
dc.relation.projectID | [01KU1912] | |
dc.relation.projectID | [3619S42261] | |
dc.relation.projectID | [2021SGR01112] | |
dc.relation.projectID | Cancer Research UK [18504] Funding Source: researchfish | |
dc.relation.publisherversion | https://doi.org/10.1016/j.breast.2023.103578 | |
dc.rights.accessRights | openAccess | * |
dc.subject.keyword | FPGMX | |
dc.typefides | Artículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis) | |
dc.typesophos | Artículo Original | |
dc.volume.number | 72 |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International
